STITCH Trial

Summary: Evaluated patients with coronary artery disease and ejection fractions < 35% with coronary artery bypass grafting (CABG) with medical therapy versus medical therapy alone. The primary endpoint of all cause mortality was not different. When adjusting for subgroup differences, CABG was favored.

Original Publication:

N Engl J Med. 2011 Apr 28;364(17):1607-16.

http://www.ncbi.nlm.nih.gov/pubmed/23121323

Eponym: Surgical Treatment for IsCHemic Heart Failure Trial